Neoadjuvant atezolizumab in combination with sequential nab-paclitaxel and anthracycline-based chemotherapy versus placebo and chemotherapy in patients with early-stage triple-negative breast cancer (IMpassion031): a randomised, double-blind, phase 3 trial

DOI Web Site Web Site 6 Citations

Journal

  • The Lancet

    The Lancet 396 (10257), 1090-1100, 2020-10

    Elsevier BV

Citations (6)*help

See more

Report a problem

Back to top